Recommended Antimicrobial Treatment for Enteric Fever in Adults
For adults with enteric fever and no drug allergies, azithromycin 500-1000 mg orally daily for 7 days is the preferred first-line treatment, particularly for infections acquired from South Asia where fluoroquinolone resistance exceeds 70%. 1, 2
Treatment Selection Based on Geographic Origin
Infections from South Asia (India, Pakistan, Bangladesh, Nepal)
- Start azithromycin 500-1000 mg orally daily for 7 days as empiric therapy due to widespread fluoroquinolone resistance (87-98% of isolates) 1, 3
- Azithromycin demonstrates superior outcomes compared to fluoroquinolones in regions with drug-resistant strains, with lower clinical failure rates (OR 0.48,95% CI 0.26-0.89) and shorter hospital stays (1 day reduction) 4, 5
- Avoid ciprofloxacin empirically for South Asian cases—over 70% of S. Typhi isolates from this region are fluoroquinolone-resistant 4, 1
- Pakistan has additional concern for extensively drug-resistant (XDR) strains (64% of isolates), which are resistant to fluoroquinolones AND third-generation cephalosporins 3
Infections from Sub-Saharan Africa
- Ciprofloxacin 500 mg orally twice daily for 7-10 days remains an acceptable alternative for African-acquired cases, as fluoroquinolone resistance rates are lower 4, 2, 6
- Fluoroquinolones achieve fever clearance within 4 days, cure rates >96%, and low relapse rates (<8%) when organisms are susceptible 4
Severe or Hospitalized Cases
- Ceftriaxone 2 g IV daily for 5-7 days for patients with sepsis, altered mental status, or inability to tolerate oral therapy 1, 2
- Switch to oral azithromycin once clinically improved and afebrile for 24 hours to complete 7-14 days total treatment 1
- Ceftriaxone shows lower treatment failure compared to gatifloxacin in culture-confirmed cases (HR 0.24,95% CI 0.08-0.73) 4
Critical Management Steps
Before Starting Antibiotics
- Obtain blood cultures immediately—highest yield within first week of symptoms (40-80% sensitivity) 4, 2
- Collect stool and urine cultures if sepsis suspected, as these become positive after the first week 4
- Do NOT delay treatment in clinically unstable patients; start empiric therapy after cultures obtained 4, 2
Antibiotic Susceptibility Testing Pitfalls
- Never rely on ciprofloxacin disc testing alone to determine fluoroquinolone susceptibility 4
- The organism must ALSO be sensitive to nalidixic acid on disc testing to be considered truly fluoroquinolone-susceptible 4
- Azithromycin susceptibility testing is not readily available, but resistance remains rare (<3% globally) 4
Alternative Regimens (When First-Line Options Unavailable)
For Susceptible Isolates
- Ofloxacin 400 mg orally twice daily for 7-10 days if confirmed fluoroquinolone-susceptible 2
- Chloramphenicol may be considered only as last resort when no other options available, though resistance patterns have changed 4, 1
Oral Step-Down Options
- Cefixime 400 mg orally once daily can be used but has higher treatment failure rates (4-37.6%) compared to other options 4
- Azithromycin remains preferred oral follow-on agent for fluoroquinolone-resistant cases 4
Treatment Duration and Monitoring
- Complete 7-14 days of appropriate antibiotic therapy to reduce relapse risk 4, 1
- Azithromycin has lowest relapse rates (<3%) compared to ceftriaxone (<8%) and fluoroquinolones 4
- Expect fever clearance within 4-5 days of appropriate therapy 4, 1
- Narrow therapy based on susceptibility results when available 2
Common Pitfalls to Avoid
- Do not assume all enteric fever is fluoroquinolone-susceptible—resistance is now the norm in South Asia, not the exception 4, 1, 3
- Do not use cefixime as first-line empiric therapy—it has unacceptably high failure rates and should be reserved for confirmed susceptible isolates 4
- Do not stop antibiotics early—inadequate treatment duration increases relapse risk, which can occur up to one month after initial treatment 7
- Do not forget to consider upper GI bleeding—though rare, gastric ulcers can develop and cause life-threatening hemorrhage 7
Special Considerations
Infants Under 3 Months
Asymptomatic Contacts
- Do not offer empiric treatment to asymptomatic contacts; implement infection control measures instead 2